BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22572548)

  • 1. Measurement of TFF3 mRNA in aspirates from thyroid nodules using mesh filtration: the first clinical trial in 130 cases.
    Yamada H; Takano T; Kihara M; Hirokawa M; Yoshida H; Watanabe M; Iwatani Y; Hidaka Y; Miyauchi A
    Endocr J; 2012; 59(7):621-30. PubMed ID: 22572548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
    Takano T
    Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of thyroid tumor cells in aspiration biopsies for aspiration biopsy nucleic acid diagnosis.
    Takano T; Higashiyama T; Uruno T; Yamada H; Yoshida H; Miyauchi A
    Head Neck; 2008 Aug; 30(8):983-90. PubMed ID: 18302262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
    Goldstein RE; Netterville JL; Burkey B; Johnson JE
    Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
    Takano T; Yamada H
    Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
    Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.
    Carpi A; Nicolini A; Gross MD; Fig LM; Shapiro B; Fanti S; Rampin L; Polico C; Rubello D
    Biomed Pharmacother; 2005 Oct; 59(9):517-20. PubMed ID: 16202555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E; Ulys A; Trakymas M
    Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm?
    Renshaw AA; Gould EW
    Arch Pathol Lab Med; 2013 Nov; 137(11):1627-9. PubMed ID: 24168500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2005 Feb; 219(1):91-6. PubMed ID: 15694668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The demise of follicular carcinoma of the thyroid gland.
    LiVolsi VA; Asa SL
    Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
    Guerra A; Carrano M; Angrisani E; Vitale M
    Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: an assessment of its diagnostic potential and pitfalls.
    Ogawa Y; Kato Y; Ikeda K; Aya M; Ogisawa K; Kitani K; Onoda N; Ishikawa T; Haba T; Wakasa K; Hirakawa K
    Surg Today; 2001; 31(2):97-101. PubMed ID: 11291721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
    Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
    Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.